Literature DB >> 10886777

Intestinal intraepithelial lymphocytes contain a CD3- CD7+ subset expressing natural killer markers and a singular pattern of adhesion molecules.

P Eiras1, F Leon, C Camarero, M Lombardia, E Roldan, A Bootello, G Roy.   

Abstract

Intestinal intraepithelial lymphocytes (i-IEL) represent one of the largest, non-organized lymphoid population in the body. They are located outside the epithelial basement membrane among the mucosal epithelial cells. We, and previously other groups, have reported the presence of a CD7+CD3-IEL subset in the epithelium of human small intestine. This subset is drastically reduced in coeliac disease (CD) patients. In the present work we accomplish a better phenotypic characterization of this CD3-IEL subset and demonstrate the expression of typical natural killer (NK) cell markers. Most, if not all, CD3-CD7+ cells express NKPR1 (CD161)[98% +/- 2] and CD122[92% +/- 6]. In addition, a variable percentage express CD2[55% +/- 16], CD94[24% +/- 18], CD56[44% +/- 21] and CD16[12% +/- 4], however, no CD57 expression was observed. Moreover, these cells contain perforin granules[75% +/- 5], supporting a potential cytolytic ability. Regarding adhesion molecules, CD18 and CD44 expression is absent, which is consistent with a limited capacity of migration. Altogether, these data suggest the presence of intraepithelial NK cells in human intestinal epithelium, a compartment where cytotoxic effectors have not been clearly defined.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886777     DOI: 10.1046/j.1365-3083.2000.00761.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  26 in total

1.  Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin.

Authors:  Carmelo Luci; Ana Reynders; Ivaylo I Ivanov; Celine Cognet; Laurent Chiche; Lionel Chasson; Jean Hardwigsen; Esperanza Anguiano; Jacques Banchereau; Damien Chaussabel; Marc Dalod; Dan R Littman; Eric Vivier; Elena Tomasello
Journal:  Nat Immunol       Date:  2008-11-23       Impact factor: 25.606

2.  Cytokine production by intestinal intraepithelial lymphocyte subsets in celiac disease.

Authors:  Francisco León; Laura Sánchez; Cristina Camarero; Garbiñe Roy
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

Review 3.  Pathogenesis of Enteropathy-Associated T Cell Lymphoma.

Authors:  Udit Chander; Rebecca J Leeman-Neill; Govind Bhagat
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

Review 4.  Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier.

Authors:  Danyvid Olivares-Villagómez; Luc Van Kaer
Journal:  Trends Immunol       Date:  2017-12-05       Impact factor: 16.687

Review 5.  Development, Homeostasis, and Functions of Intestinal Intraepithelial Lymphocytes.

Authors:  Luc Van Kaer; Danyvid Olivares-Villagómez
Journal:  J Immunol       Date:  2018-04-01       Impact factor: 5.422

6.  Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells.

Authors:  Anja Fuchs; William Vermi; Jacob S Lee; Silvia Lonardi; Susan Gilfillan; Rodney D Newberry; Marina Cella; Marco Colonna
Journal:  Immunity       Date:  2013-02-28       Impact factor: 31.745

7.  Human NK cells licensed by killer Ig receptor genes have an altered cytokine program that modifies CD4+ T cell function.

Authors:  Lin Lin; Chao Ma; Bo Wei; Najib Aziz; Raja Rajalingam; Susy Yusung; Henry A Erlich; Elizabeth A Trachtenberg; Stephan R Targan; Dermot P B McGovern; James R Heath; Jonathan Braun
Journal:  J Immunol       Date:  2014-06-16       Impact factor: 5.422

8.  A novel mucosal RORγtNKp46 cell subset is a source of interleukin-22.

Authors:  Elena Tomasello; Ana Reynders; Eric Vivier
Journal:  F1000 Biol Rep       Date:  2009-04-29

Review 9.  Organ-specific phenotypic and functional features of NK cells in humans.

Authors:  Richa Sharma; Asmita Das
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

Review 10.  Opportunities to exploit non-neutralizing HIV-specific antibody activity.

Authors:  Margaret E Ackerman; Galit Alter
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.